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Abstract— In the past decade, researchers have been able to
obtain pluripotent stem cells directly from an organism’s dif-
ferentiated cells through a process called cell reprogramming.
This opens the way to potentially groundbreaking applications
in regenerative and personalized medicine, in which ill patients
could use self-derived induced pluripotent stem (iPS) cells where
needed. While the process of reprogramming has been shown
to be possible, its efficiency remains so low after almost ten
years since its conception as to render its applicability limited
to laboratory research. In this paper, we study a mathematical
model of the core transcriptional circuitry among a set of key
transcription factors, which is thought to determine the switch
among pluripotent and differentiated cell types. By employing
standard tools from dynamical systems theory, we analyze the
effects on the system’s dynamics of overexpressing the core
factors, which is what is performed during the reprogramming
process. We demonstrate that the structure of the system is
such that it can render the switch from an initial stable steady
state (differentiated cell type) to the desired stable steady state
(pluripotent cell type) highly unlikely. This finding provides
insights into a possible reason for the low efficiency of current
reprogramming approaches.
I. INTRODUCTION
Stem cells are unspecialized precursors with the potential
to differentiate into more specialized, differentiated cell
types. In particular, embryonic stem cells (ESCs) are at the
top of the differentiation hierarchy and can give rise to any
cell in an organism [1]. This makes them popular candidates
for use in regenerative and therapeutic medicine, where
they can replace a patient’s injured or diseased cell type
of choice [2]–[4]. However, ESC therapies face a couple of
major limitations. ESCs derived from early fetal cell masses
confront various ethical controversies [5], and transplanting
another organism’s stem cells into a patient runs the risk of
failed engraftment due to the patient’s immunogenic barrier
[6].
The biological and ethical factors limiting the efficacy of
ESCs make iPS cells a much more preferred alternative, since
they face neither of these issues by their very nature. First
discovered in a seminal experiment by Yamanaka et. al in
2006, iPS cells were produced by overexpressing only four
pluripotency-related transcription factors in differentiated
cells [7]. Since then, this strategy has been used to create
a variety of iPS cells from various differentiated cell types
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[8]. However, there is still a large bottleneck in iPS cell
research due to the low efficiency of reprogramming in these
experiments, generally around 1% or much less [9]–[11].
In this paper, we investigate structural aspects of these
overexpression-based reprogramming strategies to explain
potential reasons for this failure. Specifically, we study the
dynamics of three transcription factors–Oct4, Sox2, and
Nanog (OSN)–which have emerged as the master regulatory
factors involved in pluripotency [12]–[18]. Specific levels
of OSN characterize three cell types, each represented by
a stable steady state (SSS) of the dynamic model for OSN.
These include embryonic stem cells (which are pluripotent)
and their more differentiated counterparts, the trophectoderm
(TR) and primitive endoderm (PrE) cells (which are multi-
potent).
Our dynamical systems approach is related to the well-
established Waddington epigenetic landscape metaphor [19].
In the Waddington framework, phenotypical cell types are
represented as basins of attraction in a landscape of equilib-
ria. In this model, biological cell differentiation is understood
as a transition between attractors’ basins due to stimuli ap-
plied to the underlying genetic network [20]. In our specific
case, the ESC, TR, and PrE states are basins of attraction,
and the reprogramming process aims at transforming a state
in the TR (or PrE) basin of attraction to a state in the ESC
basin of attraction.
This paper is organized as follows. In Section II, we begin
with a 3D ordinary differential equation (ODE) model for the
dynamics of OSN, which we reduce to a 2D ODE model
between Oct4 and Nanog. We then use nullcline analysis to
characterize the ESC, TR, and PrE cell types as stable steady
states (SSS) in the 2D model. In Section III, we investigate
the dynamics of overexpression-based reprogramming. We
discover that current overexpression strategies rarely succeed
in reprogramming differentiated cells (in this case, TR or PrE
cells) into pluripotent cells (ESCs, or iPS cells), due to the
nullclines’ structure.
II. MODEL
A. The Oct4-Sox2-Nanog Fully Connected Triad
Fig. 1 summarizes the early embryological steps a zygote
undergoes after fertilization to divide and differentiate into
cells with decreasing plasticity. These are the differentiation
steps which give rise to the three cell types of interest:
ESCs, TRs, and PrEs. The working hypothesis of the identity
of the molecular machinery dictating which cells go down
each path in either differentiation step is the Oct4-Sox2-
Nanog network [12]–[18]. We approximate the topology of
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Fig. 1: (A) In the first steps after fertilization, three rounds of cell
division form an 8-cell mass known as the morula. (B) The first
differentiation event occurs when an epithelial layer known as the
trophectoderm (TR) forms around the perimeter of the mass, leaving
the rest of the cells in an inner cell mass (ICM), (from which ESCs
are derived [23], [24]), pushed against the blastocoel cavity. (C) The
second differentiation event occurs when ICM cells adjacent to the
blastocoel form an epithelium known as the primitive endoderm
(PrE), leaving the rest of the cells to the epiblast lineage. [25] was
used in creating this figure.
this network as a fully connected triad (FCT) among Oct4,
Sox2, and Nanog, as shown in Fig. 2. FCTs are a class of
3-node network motifs in which all nodes directly interact
with one another. In particular, when these interactions are all
activations, these special FCTs have been shown to exhibit
the desired multi-stability properties we seek [21]. The FCT
we model here contains an additional repression mechanism,
which has been more recently suggested [22].
B. The Nonlinear 3D OSN Model
Referring to the topology of Fig. 2, the following ordinary
differential equation model based on cooperative Hill func-
tions [26] is employed to describe the dynamics of the FCT.
Let N,O and S represent the concentrations of Nanog, Oct4,
and Sox2, respectively. The model is given by
Σ3D
dN
dt
=
a1OS + b1N
2 + c1OSN
2 + η1
1 +OS +N2 + γOSN2 + dOm
− k1N
= f1(N,O, S)− k1N, (1)
dO
dt
=
a2OS + b2N
2 + c2OSN
2 + η2
1 +OS +N2 + γOSN2
− k2O
= f2(N,O, S)− k2O, (2)
dS
dt
=
a2OS + b2N
2 + c2OSN
2 + η2
1 +OS +N2 + γOSN2
− k2S
= f2(N,O, S)− k2S. (3)
In the ODEs above, the linear terms are due to dilution and
degradation, and all parameters are positive. The nonlinear
Hill function terms, denoted by fi (i=1,2), model the species’
interaction with one another. Specifically, the Hill functions
incorporate activation by the heterodimer OS, the homod-
imer N2, and the molecule OSN2. Additional features and
assumptions of model Σ3D are described below.
Fig. 2: The network of
Oct4, Sox2, and Nanog
modeled as a fully con-
nected triad (FCT).
1) Nanog Dimerization: In contrast to the models of [27],
[28], which consider Nanog as a monomer, it is treated as a
homodimer (N2) in Σ3D. This is based on strong evidence
suggesting Nanog only binds to other pluripotency factors
when dimerized [29], [30].
2) Independent Nanog Promoter Activity: The models
of [27], [28] only consider activation by Nanog when this
species is bound to the Oct4-Sox2 heterodimer. While it has
been shown that binding Oct4-Sox2 significantly strengthens
activation by Nanog [31], the species can still act as an
activator – albeit a much weaker one – when not bound to
the heterodimer. In [31], activation by Nanog when one or
both of Oct4 and Sox2 were mutated was reduced to between
6-17% of wild type activity. To capture this, independent N2
activator terms are included in the Hill functions of Σ3D. We
note the rough quantitative constraint on the relative strength
of this term to the OSN2 term when determining appropriate
values for the bi and ci parameters in sections below.
3) Repression of Nanog by Oct4: In [22], it was reported
that low levels of Oct4 were correlated with high Nanog
and higher levels of Oct4 were correlated with low Nanog.
Although no regulatory link was demonstrated, we model this
empirical observation with a higher order repressive term by
Oct4 on Nanog, (dOm,m > 2), as seen in (1). Based on
evidence suggesting Oct4 forms a heterodimer with Sox2
[32], we require that the order of repression is an even
number.
4) Equal Dynamics for Oct4 and Sox2: Given that Oct4
and Sox2 are known to work together [33] and have been
considered as the same species in previous models [22], here
we assume that their dynamics are the same. This simplifies
the analysis without affecting the main conclusions.
5) Denominator Constants Normalized to 1: The stan-
dard form of a Hill function for an activator xa is
a1(xa/ka)
n/(1 + b1(xa/ka)
n), and for a repressor xr it is
1/(1 + b1(xr/kr)
n). As seen in (1)-(3), the parameters in
the denominators of the Hill functions are set to 1 for every
activator and repressor. This is performed via normalization
as follows. Given a Hill function of the form
f(x, y) =
α1(
x
κ1
)n1 + α2(
y
κ2
)n2 + α3(
xy
κ3
)m
1 + β1(
x
κ1
)n1 + β2(
y
κ2
)n2 + β3(
xy
κ3
)m
, (4)
the substitutions X := β(1/n1)1
x
κ1
, Y := β(1/n2)2
y
κ2
allow
(4) to be rewritten as
f(X,Y ) =
α′1X
n1 + α′2Y
n2 + α′3(XY )
m
1 +Xn1 + Y n2 + γ(XY )m
, (5)
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where α′1 = α1/β1, α
′
2 = α2/β2, α
′
3 :=
κ1κ2
κ3β
1/n1
1 β
1/n2
2
1/m,
γ := β3
β
1/n1
1 β
1/n2
2
(κ1κ2κ3 )
m.
C. Model Reduction into a 2D System
To study the location and stability of the steady states of
Σ3D, we study a reduced order system given by
Σ2D
dN
dt
=
a1O
2 + b1N
2 + c1O
2N2 + η1
1 +O2 +N2 + γO2N2 + dOm
− k1N
= g1(N,O)− k1N, (6)
dO
dt
=
a2O
2 + b2N
2 + c2O
2N2 + η2
1 +O2 +N2 + γO2N2
− k2O
= g2(N,O)− k2O, (7)
which is obtained by substituting S = O in (1) and (2). We
justify this reduction with the claims below, which show that
the location and stability of steady states of Σ3D can be
studied by studying those of Σ2D.
Lemma: If (N∗, O∗, S∗) is a steady state of Σ3D, then
S∗ = O∗.
Proof: Stable states (N∗, O∗, S∗) of Σ3D satisfy:
f1(N
∗, O∗, S∗) = k1N∗, (8)
f2(N
∗, O∗, S∗) = k2O∗, (9)
f2(N
∗, O∗, S∗) = k2S∗. (10)
Substitution of (10) into (9) shows S∗ = O∗
Any steady states of Σ3D are assumed to be of the form
(N∗, O∗, O∗) in what follows. The claim below shows that
every steady state in Σ3D maps to a unique steady state in
Σ2D. Conversely, any steady state of Σ2D maps to a unique
steady state in Σ3D.
Claim 1: (N∗,O∗,O∗) is a steady state of Σ3D if and
only if (N∗, O∗) is a steady state of Σ2D.
Proof: (⇒) If (N∗, O∗, O∗) is a steady state of Σ3D, then
f1(N
∗, O∗, S∗) = k1N∗, f2(N∗, O∗, S∗) = k2N∗. Since
fi(N
∗, O∗, O∗) = gi(N∗, O∗), i = 1, 2, (11)
then we also have g1(N∗, O∗) = k1N∗ and g2(N∗, O∗) =
k2O
∗. This implies the dynamics of Σ2D satisfy N˙ =
g1(N
∗, O∗)− k1N∗ = 0 and O˙ = g2(N∗, O∗)− k2O∗ = 0.
Therefore, (N∗, O∗) is a steady state of Σ2D.
(⇐) If (N∗, O∗) is a steady state of Σ2D, then
g1(N
∗, O∗) = k1N∗, g2(N∗, O∗) = k2O∗. Due to (11),
we also have f1(N∗, O∗, O∗) = g1(N∗, O∗) = k1N∗
f2(N
∗, O∗, O∗) = g2(N∗, O∗) = k2O∗ = k2S∗, which
implies (N∗, O∗, O∗) is a steady state of Σ3D.
In addition, the claim below shows that the stability
properties of a steady state in Σ2D reflect the same properties
for the corresponding steady state in Σ3D.
Claim 2: (N∗, O∗) is a stable (unstable) steady state of
Σ2D if and only if (N∗, O∗, O∗) is a stable (unstable) steady
state of Σ3D.
Proof: We first show that 2D stability implies 3D stability.
The Jacobians of systems Σ2D and Σ3D are given by
J2D =
[
G∗1N − k1 G∗1O
G∗2N G
∗
2O − k2
]
,
J3D =
 F ∗1N − k1 F ∗1O F ∗1SF ∗2N F ∗2O − k2 F ∗2S
F ∗2N F
∗
2O F
∗
2S − k2
 ,
respectively, where F ∗iX :=
∂fi
∂X (N
∗, O∗, S∗), G∗iX :=
∂gi
∂X (N
∗, O∗). Stability of a stable state in Σ2D implies:
tr(J2D) = G∗1N +G
∗
2O − k1 − k2 < 0, (12)
det(J2D) = (G∗1N−k1)(G∗2O−k1)−G∗2NG∗1O > 0. (13)
The characteristic equation of Σ3D can be written as:
P3D(s) = s
3 + s2[−G∗1N −G∗2O + k1 + 2k2]+
s[k2(k2+2k1−G∗2O−2G∗1N )−k1G∗2O+G∗1NG∗2O−G∗2NG∗1O]
− k2G∗2NG∗1O + k2G∗1NG∗2O − k1k2G∗2O + k22G∗1N = 0,
(14)
where the relation
∂g
∂O
(N∗, O∗) =
∂f
∂O
(N∗, O∗, O∗) +
∂f
∂S
(N∗, O∗, O∗)
is used, which comes from using the chain rule on g(N,O) =
f(N,O, z(O)), z(O) = O. Equation (14) can be rewritten
to obtain
P3D(s) = s
3 + s2(k2 − tr(J2D))
+ s(det(J2D)− k2tr(J2D)) + k2det(J2D) = 0. (15)
The Routh-Hurwitz stability criterion states that a third-order
system with characteristic polynomial P (s) = a3s3+a2s2+
a1s+a0 is stable if and only if an > 0 for all n and a2a1 >
a3a0. As a consequence, the stability conditions for Σ3D
become: k2 − tr(J2D) > 0, (16)
det(J2D)− k2tr(J2D) > 0, (17)
k2det(J2D) > 0, (18)
(k2 − tr(J2D))(det(J2D)− k2tr(J2D)) > k2det(J2D). (19)
Relations (16)-(18) are trivially implied by the stability
conditions of Σ2D, while (19) can be reduced to:
tr(J2D)(k2tr(J2D)− k22 − det(J2D)) > 0,
which, in turn, is also implied by the stability conditions
(12)-(13) of Σ2D since ki > 0. This shows that stability of
(N∗, O∗) in Σ2D implies stability of (N∗, O∗, O∗) in Σ3D.
We now show that instability of (N∗, O∗) in Σ2D implies
instability of (N∗, O∗, O∗) in Σ3D. The eigenvalues of Σ2D
are
λ2D =
1
2
[
tr(J2D)±
√
tr2(J2D)− 4det(J2D)
]
, (20)
and there are two cases in which any of these are positive:
i) det(J2D) < 0 and ii) det(J2D) > 0, tr(J2D) > 0. If
(N∗, O∗) in Σ2D is unstable and we are in case i), (18)
is easily seen to be not satisfied, making Σ3D unstable. If
we are in case ii), it can be shown that conditions (16)-
(19) cannot simultaneously be satisfied. Without loss of
generality, we can assume (16)-(18) are satisfied, and test
if condition (19) is satisfied. It is satisfied if
tr(J2D)[k2tr(J2D)− k22 − det(J2D)]
= tr(J2D)[−k2(−tr(J2D) + k2)− det(J2D)] (21)
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Oct4
Levels
TR <ESC ESC <PrE
[34]–[37] [36]–[38]
Nanog
Levels
TR, PrE <ESC
[14], [18], [39]
TABLE I: Results of literature search characterizing Oct4 & Nanog
levels in TR, ESC, PrE cell states
Fig. 3: State characteriza-
tions of ESC, TR, and PrE
based on relative Oct4 and
Nanog concentrations deter-
mined from Table 1.
is positive. The right hand side of (21) is negative since
tr(J2D) > 0, det(J2D) > 0 and −k2(−tr(J2D) + k2) < 0
from assuming (16)-(18) is true. This shows that instability
of (N∗, O∗) in Σ2D implies instability of (N∗, O∗, O∗) in
Σ3D. 
By virtue of these claims, we can focus on studying the
number and stability of the steady states of Σ2D.
D. Characterizing ESC, Tr, PrE States by Oct4 and Nanog
Levels
Using experimental studies of the differentiation steps
that give rise to the ESC, TR, and PrE states, Table 1
summarizes the results of a literature search concluding with
the characterizations of the three cell types shown in Fig.
3. While the experiments show that Nanog levels in ESC
are much higher than those in TR and PrE, we found no
experimental evidence comparing Nanog levels in TR and
PrE. We assume that Nanog in PrE is at an intermediate level
between Nanog in TR and ESC. There is no loss of generality
because the strength of the parameter d in (6) can be chosen
to further decrease Nanog levels for high Oct4. With this
characterization and the mathematical framework established
above, we now form a correspondence between the SSS of
Σ2D and the physiological cell types corresponding to certain
levels of Oct4 and Nanog.
E. 2D Nullcline Analysis
We perform nullcline analysis to determine the SSS cor-
responding to the qualitative levels of Oct4 and Nanog in
each cell type seen in Fig. 3. The nullclines describing the
mathematical steady states of Σ2D at equilibrium (O˙ = N˙ =
0) are
N∗ =
√
k2O∗ − a2O∗2 + k2O∗3 − η2
b2 − k2O∗ + c2O∗2 − k2O∗3 , (22)
O∗+/− =
√
−1
d +
a1
dk1N∗
+ c1N
∗
k1d
− N∗2d ±X
2
, (23)
where we have defined
X :=
1
k1dN∗
[(−a1 + k1N∗ − c1N∗2 + k1N∗3)2
− 4dk1N∗(k1N∗ − b1N∗2 + k1N∗3 − η1)]1/2, (24)
and have set the order of Oct4 repression on Nanog to m = 4
for the sake of analysis.
The main parametric constraint used when performing this
analysis was that the strength, bi, of activator N2 should be
less than the strength, ci, of OSN2–on the order of about
0.10. This is in accordance with the experimental report [31]
showing Nanog promoter activity when Oct4 and Sox2 were
mutated was measured to be much less than wild type activity
(6-17%). In Fig. 4A, nullclines are shown for a representative
parameter set which satisfies these constraints (b1/c1 ≈ 0.27,
b2/c2 ≈ 0.09). There are five steady states, whose stability
is studied through geometric reasoning as follows.
We define H1(N,O) := g1(N,O) − k1N,H2(N,O) :=
g2(N,O)−k2O. We first study the stability of a point (N,O)
on the nullcline H2(N,O) = 0 (Fig. 4B) in the O direction.
For a fixed N , the corresponding point on the nullcine is
stable in the O direction if ∂H2/∂O < 0. Using the implicit
function theorem, we have
dO
dN
∣∣∣∣
H2=0
= −∂H2
∂N
·
(∂H2
∂O
)−1
. (25)
Graphically, the left hand side in (25) represents the local
slope of the nullcline in Fig. 4B. In our system, ∂H2/∂N >
0 for all positive (N,O). Therefore, ∂H2/∂O < 0 if and
only if dO/dN > 0. As a result, a point (N,O) on the
nullcline H2(N,O) = 0 is stable in the O direction if and
only if dO/dN is positive at (N,O).
Similarly, when studying the stability of a point (N,O)
on H1(N,O) = 0 in the N direction, we consider the
nullcline dN/dt = H1(N,O) = 0 in Fig. 4C. For a
fixed O, the steady state is stable in the N direction if
∂H1/∂N < 0. Applying the implicit function theorem, we
obtain the condition that the steady state is stable if and only
if ( dO
dN
∣∣∣∣
H1=0
)
· ∂H1
∂O
> 0, (26)
where the first term in (26) is the local slope of the null-
cline in Fig. 4C. In contrast to the previous case, however,
∂H1/∂O is not sign definite when evaluated on the nullcline
H1(N,O) = 0. To understand which segment of the null-
cline in Fig. 4C has positive (negative) ∂H1/∂O, we note
that for a fixed N = N∗, O is solved by a quadratic function
of O2,
Hˆ1(N
∗, O) := H1(N∗, O)T (N∗, O)
= −a(N∗)O4 + b(N∗)O2 + c(N∗) = 0, (27)
where a = −k1dN∗, b = a1 − k1N∗ + c1N∗2 − k1N∗3, c =
−k1N∗ − k1N∗3 + b1N∗2 + η1 and T (N∗, O) := 1 +O2 +
N∗2 +O2N∗2 > 0 is the denominator term in g1(N∗, O∗).
When (27) has two solutions O∗− (red branch in Fig. 4C) and
O∗+ (blue branch in Fig. 4C), we have
∂Hˆ1
∂O (N
∗, O∗−) > 0
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Fig. 4: Nullcline stability analysis: (A) nullclines for the parameter
set giving rise to 3 SSS: m = 4, a1 = 10, b1 = 2, c1 = 7.5, k1 =
1, η1 = 0.0001, a2 = 1.8, b2 = 0.18, c2 = 2, k2 = 1, η2 =
0.0001, γ = 1, d = 20. d is chosen to reduce Nanog levels in
PrE (high Oct4) so they remain under levels in ESC. The vector
field is plotted using Mathematica V10.0.2.0. (B) Sign of the vector
field in the O direction in the proximity of the nullcline O˙ = 0.
(C) Sign of the vector field in the N direction in the proximity of
the nullcline N˙ = 0.
and ∂Hˆ1∂O (N
∗, O∗+) < 0. Moreover, since H1(N
∗, O∗−) = 0
at (N∗, O∗−),
∂Hˆ1
∂O
(N∗, O∗−) = H1(N
∗, O∗−) ·
∂T
∂O
(N∗, O∗−)
+
∂H1
∂O
(N∗, O∗−) · T (N∗, O∗−)
=
∂H1
∂O
(N∗, O∗−) · T (N∗, O∗−) > 0, (28)
which implies that ∂H1/∂O > 0 at (N∗, O∗−). Similarly,
we can show that ∂H1/∂O < 0 at (N∗, O∗+). Therefore,
the red branch (corresponding to O∗−) is stable (unstable)
in the N direction when the local slope of the nullcline in
Fig. 4C is positive (negative). Conversely, the blue branch
(corresponding to O∗+) is stable in the N direction when the
nullcline has negative local slope, and unstable otherwise.
Given the above conclusions, since the system is in 2D, a
steady state (N∗, O∗) is stable if and only if it is stable
in both the O and N directions. According to this stability
analysis, the nullclines in Fig 4. lead to 3 SSS and 2 unstable
steady states.
III. REPROGRAMMING USING OVEREXPRESSION
In a 2006 report by Yamanaka and colleagues, a small
cocktail of only 4 transcription factors (among which were
Oct4 and Sox2) was identified as the sole requirement for
reprogramming differentiated cells into stem cells [7]. In
this experiment, adult fibroblast cells were induced into
pluripotent stem cells using the transcription factor cocktail.
Since then, a variety [8] of differentiated cells and experi-
mental conditions have been used to produce iPSCs, yet the
efficiency of reprogramming remains around 1% or much
less [9]–[11].
Here we use nullcline analysis to provide a possible ex-
planation as to why current techniques show this systematic
failure after nearly 10 years of practice. In overexpression
experiments, transcription factors are produced in excess in
a cell using viral and non-viral vectors [40]. Specifically,
the genes encoding the transcription factors are inserted into
these vectors under the control of constitutive or inducible
promoters. This effectively increases the production rate of
the factors. In our model, we therefore treat this overexpres-
sion as an additional constant term added to the production
rate of the factors. This leads to the modified system:
Σ′2D
dN
dt
=
a1O
2 + b1N
2 + c1O
2N2 + η1
1 +O2 +N2 +O2N2 + dO4
− k1N + u1, (29)
dO
dt
=
a2O
2 + b2N
2 + c2O
2N2 + η2
1 +O2 +N2 +O2N2
− k2O + u2. (30)
in which u1 and u2 are positive and can be effectively viewed
as inputs to the system. The nullclines change to
N∗ =
√
k2O∗ − a2O∗2 + k2O∗3 − η2 − u2(1 +O∗2)
b2 − k2O∗ + c2O∗2 − k2O∗3 + u2(1 + γO∗2) ,
(31)
O∗+/− =
{
1
2(dk1N∗ − du1)
[
− γk1N3+
(c1 + u1γ)N
2 − k1N + u1 + a1 ± Xˆ
]}1/2
, (32)
where we have defined
Xˆ :=
1
2(dk1N∗ − du1)
{[
γk1N
∗3 − (u1γ + c1)N∗2
+ k1N
∗ − a1 − u1
]2
− 4
[
dk1N
∗ − du1
]
·
[
− u1 − η1
+ k1N
∗ − (b1 + u1)N∗2 + k1N∗3
]}1/2
. (33)
We use these nullclines to demonstrate the potential prob-
lem in seeking to force transitions from a differentiated state
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Fig. 5: Oct4 overexpression summary
(parameters adopted from Fig. 4): (A)
Number of SSS as a function of Oct4
overexpression intensity, u2. (B) For
u2 = 0.05, the ESC state disappears.
(C) For an even higher overexpression
intensity, u2 = 0.2, the TR and ESC
states disappear, leaving only the PrE
state. (D) For specific values of u2 ≈
0.005, a near intersection occurs between
the nullclines in the region where the
ESC state originally was (Fig. 4A) (E)
When u2 ≈ 0.005 (as in Fig. 5D) and a
cell in the TR state is pushed out of its
basin of attraction due to noise, it makes a
transition to the PrE state. In the interim,
it spends time at the near-intersection
close to the original ESC state (Fig. 4A).
(F) If Oct4 overexpression is stopped sud-
denly due to dilution or degradation in the
beginning of the interim state in (E), the
transitioning cell settles into the original
ESC state, and is thus reprogrammed into
an iPSC.
to the ESC state by constant inputs u1 and u2. In particular,
we start with modeling reprogramming experiments with
only the overexpression of Oct4 (employing u2 > 0, u1 = 0),
which has been used to produce iPS cells on its own from
various differentiated cells [41]–[46]. We specifically model
an experiment reprogramming the TR state to ESC using
only Oct4, as in [46]. For the sake of completeness, we
then consider reprogramming experiments with only Nanog
overexpression (u1 > 0 and u2 = 0).
A. Oct4 Overexpression: u2 > 0, u1 = 0
1) Disappearing ESC State Explains High Failure Rate:
Fig. 5 summarizes the shapes of the modified nullclines for
different values of Oct4 overexpression, u2. The chart in
Fig. 5A shows three regimes for the number of SSS as a
function of u2. There are 3 SSS for u2 ≈ 0 (Fig. 4A), 2 SSS
for intermediate values of u2 (Fig. 5B), and 1 SSS for large
values of u2 (Fig. 5C).
In Fig. 5B, a representative value of u2 from the interme-
diate range causes the O˙ = 0 nullcline to change shape such
that the intersection located at high Nanog, intermediate Oct4
– the region characterizing the ESC state – disappears. The
TR and PrE states are still present and stable at this value of
u2, so any cell starting at these states will never reach the
ESC, which no longer exists.
In Fig. 5C, an even higher representative value of u2
causes the disappearance of the entire S-shaped region of
the O˙ = 0 nullcline, which was creating the intersection
corresponding to the TR state. As such, the system’s only
remaining SSS is located in the PrE region (high Oct4,
low/intermediate Nanog), so any cell starting in TR would
be reprogrammed into the PrE state, hence missing the ESC
state again.
These results support the idea that current reprogramming
approaches have systematically low yields because constant
overexpression shifts the nullclines in a manner to make the
stable ESC state disappear, making it impossible to drive the
system towards such a state.
2) Extremely Rare Success: Nonetheless, [46] reports
success – albeit at extremely low yields – in reprogramming
TRs to ESCs with only Oct4. Our model Σ′2D is able to
replicate this unlikely success as demonstrated in Figs. 5E
and 5F, which can be explained as follows. A narrow window
of values around u2 ≈ 0.005 results in nullclines of the form
seen in Fig. 5D, in which the O˙ = 0 nullcline loses the hump
in its shape enough to come very close to intersecting N˙ = 0
in the ESC region. This near intersection provides a window
of opportunity for a cell to become an ESC.
In particular, if a cell is in the TR state and u2 ≈ 0.005,
some intrinsic or extrinsic source of noise may push it out
of the TR’s basin of attraction and closer to the neighboring
unstable state (Fig. 5D). If this occurs, the cell could be
repelled by the unstable state, and would ultimately transition
to the PrE state as shown in Fig. 5E.
However, Fig. 5E also shows that en route to becoming a
PrE, the cell is temporarily captured in a region very close
to the original ESC state when u2, u1 = 0 (Fig. 4A). Fig.
5F shows that if u2 approached zero during this time (due
to dilution of the overexpressed Oct4), the cell settles to the
original stable ESC state, and is thus reprogrammed from
TR to ESC using only Oct4 overexpression.
The fact that successful reprogramming requires a specific
value of Oct4 overexpression levels [37], [38], in addition
to two other unlikely events occurring in series is one
explanation for why overexpression-based reprogramming
rarely succeeds in practice.
B. Nanog Overexpression: u1 > 0, u2 = 0
Although we found no reports attempting to reprogram
differentiated cells to ESCs via only Nanog overexpression,
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Fig. 6: Nanog overexpression summary
(parameters adopted from Fig. 4): (A)
Number of SSS as a function of Nanog
overexpression intensity, u1. (B) For
u1 = 0.12, the ESC state disappears. A
near intersection between the nullclines
still occurs next to where the ESC state
once was (Fig. 4A) (C) For an even
higher overexpression intensity, u1 =
0.2, the TR and ESC states disappear,
leaving only the PrE state. (D) When
u1 ≈ 0.12 (Fig. 6B) and a cell in the
TR state is pushed out of its basin of
attraction due to noise, it makes a tran-
sition to the PrE state. In the interim,
it spends time at the near-intersection
close to the original ESC state (Fig. 4A).
(E) If overexpression is stopped suddenly
due to dilution or degradation in the be-
ginning of the interim state in (D), the
transitioning cell settles into the original
ESC state, and is thus reprogrammed into
an iPSC.
we perform an analysis on Nanog analogous to the one done
above for Oct4 overexpression. We show that overexpression
of Nanog also leads to disappearance of the ESC state.
1) Disappearing ESC State Explains High Failure Rate:
Fig. 6 summarizes the nearly equivalent results for Nanog
overexpression as seen in Fig. 5 with Oct4 overexpression.
Except for a certain range of values (u1 ≈ 0.12), the
N˙ = 0 nullcline loses the hump in its shape, causing the
disappearance of ESC states (Figs. 6B, 6C).
2) Extremely Rare Success: As seen in Fig. 6D, for values
of u1 ≈ 0.12, a TR cell that is pushed out of it’s basin of
attraction is then repelled by the nearby unstable state, and
can be pushed towards the PrE state. Fig. 6D shows that
en route to the PrE state, the cell is temporary captured in a
region near the original ESC state when u2, u1 = 0. If Nanog
overexpression is removed during this temporary suspension
(u1 = 0), the cell settles to the stable ESC state and is thus
reprogrammed into an iPSC (Fig. 6E).
Although many reprogramming experiments involve the
use of multiple transcription factors, the systematic failures
demonstrated here with single-factor overexpression can be
seen to carry through if both Oct4 and Nanog were overex-
pressed at the same time (u1 > 0, u2 > 0). In fact, in this
case the nullclines would intersect for u1 = u1 = 0.2 at
points given by the intersection of O˙ = 0 in Fig. 5C and
N˙ = 0 in Fig. 6C. It can be seen by inspection that these
two nullclines intersect only once, in the PrE region.
IV. CONCLUSION
In this work, we have modeled the difficulty of iPS cell
reprogramming using standard tools from dynamical systems
theory. Our study was based on understanding transitions
among basins of attraction in a multi-stable system under
additive positive inputs. It is very well known that for some
bistable systems such as the toggle switch [47] or its variants
[48], one can always force transitions from any initial state
to any desired basin of attraction by suitable applications of
positive additive input. In contrast to this, the structure of
the network studied in this paper does not necessarily allow
such forced transitions.
In future work, we will study the general principle that
makes the distinction between networks in which such transi-
tions can be forced with positive additive inputs, and those in
which this is not possible. We will also investigate theoretical
overexpression models that use closed-loop feedback to
overcome this structural problem.
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